Literature DB >> 30021784

Ibrutinib blocks Btk-dependent NF-ĸB and NFAT responses in human macrophages during Aspergillus fumigatus phagocytosis.

Amelia Bercusson1, Thomas Colley1, Anand Shah1, Adilia Warris2, Darius Armstrong-James1,3,4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30021784      PMCID： PMC6450054          DOI： 10.1182/blood-2017-12-823393

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   25.476


× No keyword cloud information.
  15 in total

Review 1.  Bruton's tyrosine kinase inhibitors and their clinical potential in the treatment of B-cell malignancies: focus on ibrutinib.

Authors:  Amin Aalipour; Ranjana H Advani
Journal:  Ther Adv Hematol       Date:  2014-08

2.  Small-molecule kinase inhibitors: an analysis of FDA-approved drugs.

Authors:  Peng Wu; Thomas E Nielsen; Mads H Clausen
Journal:  Drug Discov Today       Date:  2015-07-23       Impact factor: 7.851

3.  Inhibition of B Cell Receptor Signaling by Ibrutinib in Primary CNS Lymphoma.

Authors:  Michail S Lionakis; Kieron Dunleavy; Mark Roschewski; Brigitte C Widemann; John A Butman; Roland Schmitz; Yandan Yang; Diane E Cole; Christopher Melani; Christine S Higham; Jigar V Desai; Michele Ceribelli; Lu Chen; Craig J Thomas; Richard F Little; Juan Gea-Banacloche; Sucharita Bhaumik; Maryalice Stetler-Stevenson; Stefania Pittaluga; Elaine S Jaffe; John Heiss; Nicole Lucas; Seth M Steinberg; Louis M Staudt; Wyndham H Wilson
Journal:  Cancer Cell       Date:  2017-05-25       Impact factor: 31.743

4.  Neutrophil development and function critically depend on Bruton tyrosine kinase in a mouse model of X-linked agammaglobulinemia.

Authors:  Katja Fiedler; Anca Sindrilaru; Grzegorz Terszowski; Enikö Kokai; Thorsten B Feyerabend; Lars Bullinger; Hans-Reimer Rodewald; Cornelia Brunner
Journal:  Blood       Date:  2010-11-09       Impact factor: 22.113

5.  Pleiotropic consequences of Bruton tyrosine kinase deficiency in myeloid lineages lead to poor inflammatory responses.

Authors:  Anita Mangla; Anupriya Khare; Varanasi Vineeth; Nagesh Narayan Panday; Asok Mukhopadhyay; Balachandran Ravindran; Vineeta Bal; Anna George; Satyajit Rath
Journal:  Blood       Date:  2004-04-29       Impact factor: 22.113

6.  Call for Action: Invasive Fungal Infections Associated With Ibrutinib and Other Small Molecule Kinase Inhibitors Targeting Immune Signaling Pathways.

Authors:  Georgios Chamilos; Michail S Lionakis; Dimitrios P Kontoyiannis
Journal:  Clin Infect Dis       Date:  2018-01-06       Impact factor: 9.079

7.  Tyrosine kinase Btk regulates E-selectin-mediated integrin activation and neutrophil recruitment by controlling phospholipase C (PLC) gamma2 and PI3Kgamma pathways.

Authors:  Helena Mueller; Anika Stadtmann; Hugo Van Aken; Emilio Hirsch; Demin Wang; Klaus Ley; Alexander Zarbock
Journal:  Blood       Date:  2010-02-18       Impact factor: 22.113

8.  Calcineurin Orchestrates Lateral Transfer of Aspergillus fumigatus during Macrophage Cell Death.

Authors:  Anand Shah; Shichina Kannambath; Susanne Herbst; Andrew Rogers; Simona Soresi; Martin Carby; Anna Reed; Serge Mostowy; Matthew C Fisher; Sunil Shaunak; Darius P Armstrong-James
Journal:  Am J Respir Crit Care Med       Date:  2016-11-01       Impact factor: 21.405

9.  Bruton's Tyrosine Kinase (BTK) and Vav1 contribute to Dectin1-dependent phagocytosis of Candida albicans in macrophages.

Authors:  Karin Strijbis; Fikadu G Tafesse; Gregory D Fairn; Martin D Witte; Stephanie K Dougan; Nicki Watson; Eric Spooner; Alexandre Esteban; Valmik K Vyas; Gerald R Fink; Sergio Grinstein; Hidde L Ploegh
Journal:  PLoS Pathog       Date:  2013-06-27       Impact factor: 6.823

10.  Bruton's tyrosine kinase is essential for NLRP3 inflammasome activation and contributes to ischaemic brain injury.

Authors:  Minako Ito; Takashi Shichita; Masahiro Okada; Ritsuko Komine; Yoshiko Noguchi; Akihiko Yoshimura; Rimpei Morita
Journal:  Nat Commun       Date:  2015-06-10       Impact factor: 14.919
View more
  40 in total

Review 1.  Bruton Tyrosine Kinase Inhibitors: Present and Future.

Authors:  Jan A Burger
Journal:  Cancer J       Date:  2019 Nov/Dec       Impact factor: 3.360

Review 2.  Inhibiting Bruton's Tyrosine Kinase in CLL and Other B-Cell Malignancies.

Authors:  Fabienne Lucas; Jennifer A Woyach
Journal:  Target Oncol       Date:  2019-04       Impact factor: 4.493

Review 3.  Aspergillus fumigatus and Aspergillosis in 2019.

Authors:  Jean-Paul Latgé; Georgios Chamilos
Journal:  Clin Microbiol Rev       Date:  2019-11-13       Impact factor: 26.132

4.  Incidence of opportunistic infections during ibrutinib treatment for B-cell malignancies.

Authors:  Kerry A Rogers; Luay Mousa; Qiuhong Zhao; Seema A Bhat; John C Byrd; Zeinab El Boghdadly; Tomas Guerrero; Lauren B Levine; Fabienne Lucas; Polina Shindiapina; Audrey M Sigmund; Matthew Sullivan; Tracy E Wiczer; Jennifer A Woyach; Farrukh T Awan
Journal:  Leukemia       Date:  2019-05-13       Impact factor: 11.528

Review 5.  Menacing Mold: Recent Advances in Aspergillus Pathogenesis and Host Defense.

Authors:  Benjamin Y Tischler; Tobias M Hohl
Journal:  J Mol Biol       Date:  2019-04-04       Impact factor: 5.469

Review 6.  Managing toxicities of Bruton tyrosine kinase inhibitors.

Authors:  Andrew Lipsky; Nicole Lamanna
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2020-12-04

Review 7.  How I manage ibrutinib intolerance and complications in patients with chronic lymphocytic leukemia.

Authors:  Deborah M Stephens; John C Byrd
Journal:  Blood       Date:  2019-01-14       Impact factor: 22.113

8.  Immunomodulatory effects of pevonedistat, a NEDD8-activating enzyme inhibitor, in chronic lymphocytic leukemia-derived T cells.

Authors:  Scott Best; Vi Lam; Tingting Liu; Nur Bruss; Adam Kittai; Olga V Danilova; Susan Murray; Allison Berger; Nathan D Pennock; Evan F Lind; Alexey V Danilov
Journal:  Leukemia       Date:  2020-03-16       Impact factor: 11.528

9.  Fungal Infections with Ibrutinib and Other Small-Molecule Kinase Inhibitors.

Authors:  Marissa A Zarakas; Jigar V Desai; Georgios Chamilos; Michail S Lionakis
Journal:  Curr Fungal Infect Rep       Date:  2019-07-05

10.  Genetic variation and fungal infection risk: State of the art.

Authors:  Michail S Lionakis
Journal:  Curr Fungal Infect Rep       Date:  2019-11-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.